Top Markets
Coin of the day
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Rank in Stocks #33743
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Share Price
$4.58
Last synced: 2025-05-09
Market Cap
$6.98M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade NeuroMetrix, Inc. (NURO)

Category

Revenue for NeuroMetrix, Inc. (NURO)
Revenue in Dec 2024 TTM: $3.03M
According to NeuroMetrix, Inc. latest financial reports the company's current revenue (TTM) is $3.03M. In 2023 the company made a revenue of $5.90M a decrease compared to the revenue in the year 2022 that was $8.26M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NeuroMetrix, Inc. from 2001 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $3.03M 0.00%
2024 $3.03M -48.61%
2023 $5.90M -28.52%
2022 $8.26M 0.03%
2021 $8.25M 11.87%
2020 $7.38M -20.43%
2019 $9.27M -42.37%
2018 $16.09M -5.86%
2017 $17.09M 42.11%
2016 $12.03M 64.76%
2015 $7.30M 32.42%
2014 $5.51M 4.43%
2013 $5.28M -30.32%
2012 $7.58M -27.14%
2011 $10.40M -25.20%
2010 $13.90M -46.82%
2009 $26.14M -16.01%
2008 $31.12M -30.26%
2007 $44.62M -19.24%
2006 $55.25M 61.09%
2005 $34.30M 91.39%
2004 $17.92M 95.47%
2003 $9.17M 116.98%
2002 $4.23M 21.96%
2001 $3.46M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.59B 1,535,920.56%
US
$25.84B 851,808.63%
US
$35.48B 1,169,893.64%
IE
$21.00B 692,189.10%
US
$6.51B 214,626.34%
US